Ultrasonographic features and clinical implications of benign palpable breast lesions in young women.
- Author:
Richard HA
1
;
Hyonah KIM
;
Victoria MANGO
;
Ralph WYNN
;
Christopher COMSTOCK
Author Information
- Publication Type:Original Article
- Keywords: Breast; Breast diseases; Young adult; Ultrasonography
- MeSH: Biopsy; Breast Diseases; Breast*; Diagnosis; Female; Humans; Information Systems; Pathology; Subject Headings; Ultrasonography; Ultrasonography, Mammary; Young Adult
- From: Ultrasonography 2015;34(1):66-70
- CountryRepublic of Korea
- Language:English
- Abstract: PURPOSE: The purpose of this study was to describe the breast ultrasonography (US) features and to investigate whether performing a core biopsy is warranted in young women having palpable solid breast masses. METHODS: A total of 76 solid palpable masses in 68 consecutive women (< or =25 years old) underwent tissue diagnosis by percutaneous core biopsy. Two radiologists, who were blinded to the clinical history and histopathology, independently evaluated the US features according to Breast Imaging-Reporting and Data System (BI-RADS) lexicon. The frequency of benign and malignant descriptor terms that were used to characterize the lesions were compared to the final pathology. RESULTS: All 76 palpable solid masses yielded benign pathology. On the US, the shape of the mass was described by radiologists 1 and 2 as oval or round (63.2% and 71.1%), margin as circumscribed (68.4% and 77.6%) and orientation as parallel (85.5% and 90.8%); the frequency of using all three benign descriptors was 61.8% and 68.5%, respectively. Suspicious descriptors were used less frequently by radiologists 1 and 2 including irregular shape (9.2% and 13.1%), non-circumscribed margin (31.6% and 22.4%) and non-parallel orientation (14.5% and 9.2%); the frequency of using all three suspicious descriptors was 9.2% and 11.8%, respectively. CONCLUSION: Despite the variable US features, breast malignancy seems extremely low in 25 years or younger women for palpable breast lesions. Using the BI-RADS lexicon, US accurately predicted benignity in about two thirds of our patients, supporting US surveillance as a safe alternative to invasive tissue sampling in this setting.
